Cryptic Splicing Events in the Iron Transporter ABCB7 and Other Key Target Genes in SF3B1 Mutant Myelodysplastic Syndromes
Europe PMC Funders Group Author Manuscript Leukemia. Author manuscript; available in PMC 2016 December 13. Published in final edited form as: Leukemia. 2016 December ; 30(12): 2322–2331. doi:10.1038/leu.2016.149. Europe PMC Funders Author Manuscripts Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes Hamid Dolatshad#1, Andrea Pellagatti#1, Fabio G. Liberante2, Miriam Llorian3, Emmanouela Repapi4, Violetta Steeples1, Swagata Roy1, Laura Scifo1, Richard N. Armstrong1, Jacqueline Shaw1, Bon Ham Yip1, Sally Killick5, Rajko Kušec6, Stephen Taylor4, Kenneth I. Mills2, Kienan I. Savage2, Christopher W. J. Smith3, and Jacqueline Boultwood1 1Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, and NIHR Biomedical Research Centre, Oxford, OX3 9DU, UK 2Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast BT9 7AE, UK 3Department of Biochemistry, Downing Site, University of Cambridge, Cambridge CB2 1QW, UK 4The Computational Biology Research Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK 6Dubrava University hospital and Zagreb School of Medicine, University of Zagreb, 10000 Zagreb, Croatia Europe PMC Funders Author Manuscripts # These authors contributed equally to this work. Abstract The splicing factor SF3B1 is the most frequently mutated gene in the myelodysplastic syndromes (MDS), and is strongly associated with the presence of ring sideroblasts (RS). We have performed a systematic analysis of cryptic splicing abnormalities from RNA-sequencing data on hematopoietic stem cells (HSCs) of SF3B1-mutant MDS cases with RS.
[Show full text]